Studies finds Mounjaro (Tirzepatide) Superior to Ozempic (Semaglutide) for Blood sugar control and Weight Loss
A comparison of two drugs used to treat type 2 diabetes found that tirzepatide (Mounjaro) was superior to semaglutide (Ozempic) at blood sugar control (glucose) and promoting weight loss. A meta-analysis of 22 randomized controlled trials were just presented at the annual meeting of the European Association for the Study of Diabetes in October. Of the 22 trials included […]
More